Glytec and ThunderCat Technology Partner to Improve Glycemic Management at VA Hospitals

Glytec and ThunderCat Technology Partner to Improve Glycemic Management at VA Hospitals Collaboration Seeks to Improve Outcomes and Reduce Cost of Care for the 25% of Veterans with Diabetes WALTHAM, MASS. (July 7, 2020) – Glytec, the only provider of insulin management software across the continuum of care, and ThunderCat Technology, a Service-Disabled Veteran-Owned Small Business (SDVOSB) that delivers technology …

June 16, 2020

5 Reasons Why Providers Need Electronic Support for Glycemic Management

JUNE 2020 ROBBY BOOTH 5 Reasons Why Providers Need Electronic Support for Glycemic Management It’s no secret hyperglycemia and hypoglycemia are associated with adverse outcomes in hospitalized patients. We’ve known for many years that hyperglycemia is widespread in the hospital, causes immune dysfunction, higher rates of infection, a longer length of hospital stay, complications, and even death. Insulin has been …

June 15, 2020

Bruce Bode, MD: Impact of COVID-19 on Diabetes Care and Endocrinology

JUNE 2020 PATRICK CAMPBELL Bruce Bode, MD: Impact of COVID-19 on Diabetes Care and Endocrinology The impact of the coronavirus disease 2019 (COVID-19) outbreak on endocrinology has been impossible to ignore. With diabetic patients at increased risk of developing serious complications, endocrinologists have had to keep a keen eye on the latest on the disease for the wellbeing of their …

Onduo, Medtronic, Abbott, Glytec present diabetes management study data at ADA 2020 virtual conference

JUNE 2020 DAVE MUOIO Onduo, Medtronic, Abbott, Glytec present diabetes management study data at ADA 2020 virtual conference From virtual management programs to hybrid closed loop systems, diabetes management companies put the spotlight on improved blood glucose management and positive clinical outcomes. The American Diabetes Association’s 80th Scientific Sessions kicked off this weekend, and a handful of diabetes management device-makers …

Glytec’s Glucommander Software Combined with Continuous Glucose Monitoring Enables Patients with Diabetes to Improve Time in Range by More than 25% in Only Four Weeks

Glytec’s Glucommander Software Combined with Continuous Glucose Monitoring Enables Patients with Diabetes to Improve Time in Range by More than 25% in Only Four Weeks First study to utilize CGM data with FDA-cleared, cloud-based titration software suggests significantly improved outcomes for patients while optimizing clinical resources WALTHAM, MASS. (June 16, 2020) – Glytec, the only provider of insulin management software across …

June 13, 2020

Preventing Hypoglycemia, Hyperglycemia with Insulin and Glucagon Coadministration

JUNE 2020 PATRICK CAMPBELL Preventing Hypoglycemia, Hyperglycemia with Insulin and Glucagon Coadministration Attempting to prevent hypoglycemia without worsening hyperglycemia in those with type 1 diabetes has been a challenge for clinicians for decades, but results of a new study from the American Diabetes Association’s (ADA) 80th Scientific Sessions signal there could be a change on the horizon. Results of the 11-person proof-of-concept trial …

June 11, 2020

Healthcare Providers Showcase Value of Glytec’s Insulin Management Software During Diabetes Technology Society’s Virtual Hospital Poster Session

Healthcare Providers Showcase Value of Glytec’s Insulin Management Software During Diabetes Technology Society’s Virtual Hospital Poster Session Event Includes Six Studies on Quality and Cost Improvements Achieved Through Glytec eGMS® WALTHAM, MASS. (June 11, 2020) – Glytec, the only provider of insulin management software across the continuum of care, announced today that healthcare providers from five separate health systems will present studies …

June 4, 2020

Pandemic Parallels: Glycemic Control in COVID-19 Patients

MAY 2020 DEREK BAGLEY Pandemic Parallels: Glycemic Control in COVID-19 Patients As the COVID-19 pandemic continues to roil the world’s healthcare systems, endocrinologists may have unique insights that could save lives and improve outcomes in these patients who present with elevated glucose levels and other underlying comorbidities such as obesity and diabetes. At a Glance Patients with diabetes who contract …

April 27, 2020

Uncontrolled hyperglycemia might be COVID-19 mortality risk factor

APRIL 27, 2020 Eleanor McDermid Uncontrolled hyperglycemia might be COVID-19 mortality risk factor medwireNews: A descriptive analysis of US patients with COVID-19 reports a high in-hospital mortality rate in those with uncontrolled hyperglycemia. The rate was markedly higher than that seen in patients with confirmed diabetes, although Valerie Garrett (Glytec Inc., Waltham, Massachusetts, USA) and co-researchers note that they did …

COVID-19 death rates ‘four times higher’ among those with diabetes and hyperglycemia

APRIL 27, 2020 Mike Watts COVID-19 death rates ‘four times higher’ among those with diabetes and hyperglycemia Hospital teams are being urged to focus on glycemic management among COVID-19 patients with diabetes and hyperglycemia after a research team found mortality rates are higher in people with diabetes. An American team from the Emory University School of Medicine in Georgia say death rates are …

April 25, 2020

Uncontrolled hyperglycemia, diabetes drive longer hospital stay, mortality in COVID-19

APRIL 25, 2020 Regina Schaffer  Uncontrolled hyperglycemia, diabetes drive longer hospital stay, mortality in COVID-19 Adults with diabetes or uncontrolled hyperglycemia hospitalized with COVID-19 experienced a longer length of stay and markedly higher mortality compared with adults without diabetes or uncontrolled hyperglycemia, according to findings published in the Journal of Diabetes Science and Technology. Despite growing evidence that diabetes is …

Risk of Death from COVID-19 Four Times Greater for Those with Diabetes

APRIL 23, 2020 Brian Mastroianni Risk of Death from COVID-19 Four Times Greater for Those with Diabetes People living with diabetes may be at four times greater risk for death from COVID-19 than those who don’t live with the condition. New research has found that people with diabetes and poorly managed hyperglycemia who are hospitalized for COVID-19 have a death …

April 24, 2020

COVID-19 Outcomes Worse With Diabetes, Hyperglycemia

APRIL 24, 2020 COVID-19 Outcomes Worse With Diabetes, Hyperglycemia Length of stay longer, mortality higher for those with diabetes and/or acutely uncontrolled hyperglycemia. Diabetes and/or uncontrolled hyperglycemia occur frequently among hospitalized patients with COVID-19 and are associated with worse outcomes, according to a study accepted for publication in the Journal of Diabetes Science and Technology. Bruce Bode, M.D., from Atlanta …

April 22, 2020

Healthcare Providers Share Results of Computer-Guided Insulin Dosing through Glytec During Diabetes Technology Society’s Virtual Hospital Meeting

Healthcare Providers Share Results of Computer-Guided Insulin Dosing through Glytec During Diabetes Technology Society’s Virtual Hospital Meeting AdventHealth and CHI Franciscan Lead Three-Part Session with Data on Quality and Cost Improvements Achieved Through Electronic Glucose Management WALTHAM, Mass. (April 22, 2020) – Glytec, the only provider of insulin management software across the continuum of care, announced today that AdventHealth and …

April 20, 2020

Study: Pay Attention to In-Hospital Glucose to Save Lives in COVID-19

APRIL 20, 2020 Miriam E. Tucker Study: Pay Attention to In-Hospital Glucose to Save Lives in COVID-19 Diabetes and hyperglycemia among people without prior diabetes are strong predictors of mortality among hospitalized patients with COVID-19, new research suggests. The data suggest that although glycemic control may not be at the forefront of most clinicians’ minds when it comes to COVID-19, …

April 19, 2020

Study: Demanding Better Diabetes Care in Hospitals

APRIL 19, 2020 Mike Hoskins Study: Demanding Better Diabetes Care in Hospitals Poor diabetes care in hospitals has been an issue for some time, but it becomes an even more critical concern as our healthcare workers are being stretched to their breaking point dealing with COVID-19. For many people with diabetes (PWDs), the scariest part about contracting a severe case of the …

April 17, 2020

Study: Patients with COVID-19, Diabetes, Uncontrolled Hyperglycemia Have Significantly Higher Mortality

According to new data from a quality improvement study, patients with diabetes experienced no diabetes-related readmissions, urgent care visits, or emergency department visits within 30 days of hospital discharge when their healthcare providers used Glytec’s eGlycemic Management System to guide insulin regimens prescribed at discharge.

Researchers at Eastern Virginia Medical School conducted the study and presented their findings earlier this month at the 17th Annual Diabetes Technology Meeting in Bethesda, Maryland.

Diabetes patients at four times greater risk of death from COVID-19

APRIL 17, 2020 Diabetes patients at four times greater risk of death from COVID-19 Diabetic and hyperglycemic patients who contract COVID-19 are more than four times as likely to have complications that result in either death or longer hospital stays than their peers without those co-morbidities, according to a new study. An analysis of more than 1,100 COVID-19 patients hospitalized …